Belite Bio, Inc. (BLTE)
178.30
-4.86
(-2.65%)
USD |
NASDAQ |
Sep 10, 11:46
Belite Bio Market Cap : 7.181B for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 7.376B |
| September 08, 2026 | 7.766B |
| September 04, 2026 | 7.797B |
| September 03, 2026 | 6.890B |
| September 02, 2026 | 6.470B |
| September 01, 2026 | 6.311B |
| August 31, 2026 | 6.271B |
| August 28, 2026 | 6.110B |
| August 27, 2026 | 6.323B |
| August 26, 2026 | 6.310B |
| August 25, 2026 | 6.511B |
| August 24, 2026 | 6.398B |
| August 21, 2026 | 6.486B |
| August 20, 2026 | 6.522B |
| August 19, 2026 | 6.788B |
| August 18, 2026 | 6.547B |
| August 17, 2026 | 6.573B |
| August 14, 2026 | 6.556B |
| August 13, 2026 | 6.696B |
| August 12, 2026 | 7.206B |
| August 11, 2026 | 7.152B |
| August 10, 2026 | 6.736B |
| August 07, 2026 | 6.536B |
| August 06, 2026 | 6.440B |
| August 05, 2026 | 6.353B |
| Date | Value |
|---|---|
| August 04, 2026 | 6.304B |
| August 03, 2026 | 6.205B |
| July 31, 2026 | 6.358B |
| July 30, 2026 | 6.410B |
| July 29, 2026 | 6.111B |
| July 28, 2026 | 6.251B |
| July 27, 2026 | 6.351B |
| July 24, 2026 | 6.147B |
| July 23, 2026 | 6.264B |
| July 22, 2026 | 6.299B |
| July 21, 2026 | 6.457B |
| July 20, 2026 | 6.127B |
| July 17, 2026 | 6.016B |
| July 16, 2026 | 6.040B |
| July 15, 2026 | 5.992B |
| July 14, 2026 | 5.880B |
| July 13, 2026 | 5.894B |
| July 10, 2026 | 5.986B |
| July 09, 2026 | 6.143B |
| July 08, 2026 | 6.105B |
| July 07, 2026 | 6.321B |
| July 06, 2026 | 6.174B |
| July 02, 2026 | 5.878B |
| July 01, 2026 | 5.705B |
| June 30, 2026 | 6.173B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 39.03M |
| CorMedix, Inc. | 621.34M |
| Eloxx Pharmaceuticals, Inc. | 66.60M |
| Cannabis Global, Inc. | 0.6564M |
| Breakthrough Chemistry, Inc. | 2.140M |
Market Cap Related Metrics
| PEG Ratio | -0.8525 |
| Price to Book Value | 9.246 |
| Price | 178.30 |
| Earnings Yield | -1.53% |
| PEGY Ratio | -0.8525 |